TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Mean Excess Weight Loss (EWL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calorie intake decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consistency of condom use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of unprotected sex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SOAP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SOPP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SF-MPQ scores
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Cervical disease regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Normal biopsy, normal Papanicolaou smear, and negative HPV test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Improvement in understanding diabetes
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Reduction in the mean number of colorectal polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in polyp burden (sum of polyp diameters)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cyclosporin blood level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Organ-space SSI rate
Endpoint domain: Adverse events/effects
Primary endpoint: gross motor scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective effects
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: VSMC migration capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of treatment for CPSP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety profile of treatment for CPSP
Endpoint domain: Adverse events/effects
Primary endpoint: Acquisition of vancomycin-resistant enterococci
Endpoint domain: Adverse events/effects
Primary endpoint: NRS pain at 72h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relative edema volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relative hematoma absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BOP scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of phase III-like activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean propagation velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Postprandial duodenal motility disruption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: ASDD-Item 2 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: δ13C value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean score of image quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of inadequate images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower limb muscle strength (SHF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: posttest scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum concentration (Cmax) of cycloserine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Higher injury frequency in users of expensive athletic shoes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression Scale (CGIS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of study tests ordered
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: tolerability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: motor performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Time to vocal cord visualisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Requirement for lidocaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insertion failures
Endpoint domain: Adverse events/effects
Primary endpoint: OPI values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symptoms of dry eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: emergency target vessel revascularization, recurrent myocardial infarction, or cardiovascular mortality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hormone levels (FSH, LH, PRL, E2, E1, SHBG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Improvement in Oxford Hip Score (OHS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Efficacy against vivax malaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean annual rates of decline in distance visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean annual rates of decline in retinal visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to onset of pruritus
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in serum CTX
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in urinary CTX
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean SABP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LVAD knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with life after implantation
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 3-month responder rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of gadodiamide administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events associated with gadodiamide administration
Endpoint domain: Adverse events/effects
Primary endpoint: absolute pVO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total histological activity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Conjunctival redness response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: isokinetic extension peak torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: pain on walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cardio-respiratory fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: distance walked over 10 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of price discounts and nutrition education on food purchases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroresponses to yellow fever immunization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: long-term clinical outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: non-fatal events
Endpoint domain: Adverse events/effects
Primary endpoint: second breast cancer events
Endpoint domain: Mortality/survival
Primary endpoint: Severity of the disease (overall clinical score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MS Walking Scale (12-item) version 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MS Impact Scale (29-item) version 2 (MSIS-29vs2) physical
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MSIS-29vs2 psychological
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevention of falls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean cumulative ICP burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean daily ICP burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean number of ICU days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: reflex reaction time in hamstrings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reflex reaction time in gastrocnemius
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knee joint angle-repositioning error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical efficacy rates (cure or improvement)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Verbal dyspnea index
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of quintuple mutant infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Perceived understanding of disease and treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cumulative 5-year survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Median hepatic recurrence free time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specific airway resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Metastasis/Death (M/D)
Endpoint domain: Mortality/survival
Primary endpoint: Psychomotor vigilance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: autonomy
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Total effective rate for mild symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total effective rate for severe symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trial recruitment rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Area under the time-concentration curves (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: heart rate at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: work time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stair climbing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of ampules of FSH needed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of follicles obtained
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative over report of sensations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Back pain prevalence after 6 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity measured by visual analog score after 6 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: drop in patient platelet count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Overall pCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSN grade 3-4
Endpoint domain: Adverse events/effects
Primary endpoint: Median relative total dose intensity (mRTDI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: femoral neck BMD loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: femoral neck vBMD loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: Delta O2/Delta W ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased red blood cell donations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased hemoglobin deferrals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rating of operative skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Levels of S100beta and NSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Grade 3-4 toxic events
Endpoint domain: Adverse events/effects
Primary endpoint: U‐A excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: U‐IV excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Arterial blood oxygen partial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived task difficulty
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean volume of pleural drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of non-opioid psychotropic medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean serum AMH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Platelet function assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: High platelet reactivity (HPR) identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reduction in angina pectoris episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Satisfaction with therapeutic outcome
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Composite outcome of death or readmission within 30 days of hospital discharge
Endpoint domain: Mortality/survival
Primary endpoint: Readmission within 30 days of hospital discharge
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to readmission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: primary composite end point at 3 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Medio‐Lateral Stability Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medio‐Lateral Mean Deflection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreased time to additional breast cancer events
Endpoint domain: Mortality/survival
Primary endpoint: best spectacle-corrected visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine protein-creatinine ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: eGFR (estimated Glomerular Filtration Rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: HDRS score at week 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rates (>or=50% decrease in baseline HDRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drop in FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Skin test reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Symptom and medication scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: re-recurrence arising from the common femoral vein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Willingness to use a contraceptive pill
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: BP scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PF scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Significant distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of responders at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement on VR test measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance on real street crossing measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HCAHPS discharge communication domain scores
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Average vital sign parameters (HR/SBP/DBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in SFs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decisional conflict about banking sperm
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Probability of remaining in study without exacerbating asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of esophageal contractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total costs associated with comorbidity
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost for medical aids
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Child fruit and vegetable consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postthoracotomy pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lung function test results (forced expiratory volume)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 6-minute walking test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to next exacerbation requiring hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: exercise ischemic parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 30-day death/myocardial infarction/urgent target vessel revascularization
Endpoint domain: Mortality/survival
Primary endpoint: major and minor bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: systolic and diastolic hypertensive load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Risk of conversion to multiple sclerosis
Endpoint domain: Mortality/survival
Primary endpoint: Postoperative sensitivity to masticatory forces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental choice of early surgery
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in erythema index measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: decrease in combined medication and symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proliferative response to timothy grass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of pneumonitis > or = Grade 2
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of lung fibrosis
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of esophagitis > or = Grade 2
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of new-onset diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lesion length measured by CAG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in CGI-S scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in CGI-I scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean improvement in DSM-IV ADHD RS and SDS total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost per malaria case averted
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence and severity of sore throat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of hoarseness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean serum albumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Model for End-Stage Liver Disease score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in papulopustular lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction in postoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of analgesia as defined by the first PCA use time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total amount of pethidine consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Alleviation of ADHD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes